Wen Q - Search Results

1

ANP32A regulates histone H3 acetylation and promotes leukemogenesis.

Yang X, Lu B, Sun X, Han C, Fu C, Xu K, Wang M, Li D, Chen Z, Opal P, Wen Q, Crispino JD, Wang QF, Huang Z. Yang X, et al. Among authors: wen q. Leukemia. 2018 Jul;32(7):1587-1597. doi: 10.1038/s41375-018-0010-7. Epub 2018 Feb 2. Leukemia. 2018. PMID: 29467488

2

ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia.

Sun X, Lu B, Han C, Qiu W, Jin Q, Li D, Li Q, Yang Q, Wen Q, Opal P, Kini AR, Crispino JD, Huang Z. Sun X, et al. Among authors: wen q. Blood Cancer J. 2017 Dec 22;7(12):661. doi: 10.1038/s41408-017-0031-x. Blood Cancer J. 2017. PMID: 29269781 Free PMC article. No abstract available.

3

AKT activation is a feature of CALR mutant myeloproliferative neoplasms.

Fu C, Wen QJ, Marinaccio C, Ling T, Chen W, Bulic M, Lasho T, Tefferi A, Crispino JD, Xu K. Fu C, et al. Leukemia. 2019 Jan;33(1):271-274. doi: 10.1038/s41375-018-0224-8. Epub 2018 Aug 6. Leukemia. 2019. PMID: 30082822 Free PMC article. No abstract available.

4

AKT is a therapeutic target in myeloproliferative neoplasms.

Khan I, Huang Z, Wen Q, Stankiewicz MJ, Gilles L, Goldenson B, Schultz R, Diebold L, Gurbuxani S, Finke CM, Lasho TL, Koppikar P, Pardanani A, Stein B, Altman JK, Levine RL, Tefferi A, Crispino JD. Khan I, et al. Among authors: wen q. Leukemia. 2013 Sep;27(9):1882-90. doi: 10.1038/leu.2013.167. Epub 2013 Jun 10. Leukemia. 2013. PMID: 23748344 Free PMC article.

5

Normal and malignant megakaryopoiesis.

Wen Q, Goldenson B, Crispino JD. Wen Q, et al. Expert Rev Mol Med. 2011 Oct 21;13:e32. doi: 10.1017/S1462399411002043. Expert Rev Mol Med. 2011. PMID: 22018018 Free PMC article. Review.

6

Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation.

Goldenson B, Kirsammer G, Stankiewicz MJ, Wen QJ, Crispino JD. Goldenson B, et al. Blood. 2015 Mar 26;125(13):2141-50. doi: 10.1182/blood-2014-12-615401. Epub 2015 Feb 10. Blood. 2015. PMID: 25670627 Free PMC article.

7

Kinase signaling and targeted therapy for primary myelofibrosis.

Yang Q, Crispino JD, Wen QJ. Yang Q, et al. Among authors: wen qj. Exp Hematol. 2017 Apr;48:32-38. doi: 10.1016/j.exphem.2016.12.007. Epub 2016 Dec 30. Exp Hematol. 2017. PMID: 28043820 Free PMC article. Review.

8

PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN.

Liu L, Wen Q, Gong R, Gilles L, Stankiewicz MJ, Li W, Guo M, Li L, Sun X, Li W, Crispino JD, Huang Z. Liu L, et al. Among authors: wen q. Cell Death Dis. 2014 Jan 9;5(1):e988. doi: 10.1038/cddis.2013.512. Cell Death Dis. 2014. PMID: 24407241 Free PMC article.

9

Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation.

Nitulescu II, Meyer SC, Wen QJ, Crispino JD, Lemieux ME, Levine RL, Pelish HE, Shair MD. Nitulescu II, et al. EBioMedicine. 2017 Dec;26:112-125. doi: 10.1016/j.ebiom.2017.11.013. Epub 2017 Nov 21. EBioMedicine. 2017. PMID: 29239838 Free PMC article.

10

Survivin is not required for the endomitotic cell cycle of megakaryocytes.

Wen Q, Leung C, Huang Z, Small S, Reddi AL, Licht JD, Crispino JD. Wen Q, et al. Blood. 2009 Jul 2;114(1):153-6. doi: 10.1182/blood-2008-11-190801. Epub 2009 Apr 1. Blood. 2009. PMID: 19339696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,178 results

Search Page